# Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor

> **NCT07314229** · NA · RECRUITING · sponsor: **University Hospital, Lille** · enrollment: 130 (estimated)

## Conditions studied

- Cystic Fibrosis (CF)
- Mucoviscidosis

## Interventions

- **DEVICE:** Measurement of resistance through forced oscillations and continuous measurement of ventilation and inspiratory capacity during TM6

## Key facts

- **NCT ID:** NCT07314229
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-17
- **Primary completion:** 2027-02-02
- **Final completion:** 2027-04-04
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2026-04-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07314229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07314229, "Prevalence of Exercise-induced Ventilatory Limitation and Associated Factors in Patients With Cystic Fibrosis Receiving Elexacaftor-Tezacaftor-Ivacaftor". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07314229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*